NEKO PHARMA
Board
1 director, since incorporationMandate holder
appointed by deed of 01-09-2016
term without a fixed end
listed in the 2025 annual accounts, filed on 26-08-2026
Mandates through the years
1 name, the dashed line is todayMandate holder
Board
Mandates as a list
-
- Mandate holder, appointed by deed of 01-09-2016, still in office
Control
Founders
,
This company
NEKO PHARMA
Equity €413,630
Profit €29,665 in 2025
Capital
- Capital
- €18,600
- Shares
- 100
- Contribution per share
- €186
- Equity per share
- €4,136 in 2025
- Source
- deed of 01-09-2016
Articles of association
deed of 01-09-2016 (in French)- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Fourth Thursday of June at 19:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- Le ou les gérants en exercice, à moins que l'assemblée générale ne désigne un ou plusieurs liquidateurs, après paiement de toutes dettes, charges et frais de li…
Shareholders
At incorporation
deed of 01-09-2016 ↗
- 99 shares (99%) · in cash
- 1 share (1%) · in cash